Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2883837

CC(C)N(CCNC(=O)NCC(N)=O)C(C)C.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.35
KDM5B Q9UGL1 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
SLC22A2 O15244 1/20 0.31
SLC22A1 O15245 1/20 0.31
PGR P06401 1/20 0.31
THRB P10828 1/20 0.31
ADRB3 P13945 1/20 0.31
OPRK1 P41145 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
KCNH2 Q12809 1/20 0.31
PDE3A Q14432 1/20 0.31
SLC47A1 Q96FL8 1/20 0.31
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CHRM2 P08172 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2883842 0.85 SIGMAR1 (0.36) SIGMAR1KDM5BBCHEACHECHRM2
SCHEMBL2883840 0.77 ALDH1A1 (0.46) SIGMAR1KDM5BBCHEACHECHRM2
Trifluoroacetic Acid SCHEMBL2887267 0.75 EPHX2 (0.35) CHRM2CHRM1CHRM3
SCHEMBL7175314 0.73 SIGMAR1 (0.42) SIGMAR1KDM5BBCHEACHECHRM2
SCHEMBL4374960 0.73 SIGMAR1 (0.39) SIGMAR1KDM5BBCHEACHE
SCHEMBL6560529 0.70 ACHE (0.42) SIGMAR1KDM5BBCHEACHESLC22A2
SCHEMBL1911254 0.70 KDM4E (0.40) SIGMAR1KDM5BBCHEACHETSHR
SCHEMBL25230992 0.69 SIGMAR1 (0.46) SIGMAR1KDM5BBCHEACHECHRM2
SCHEMBL13298011 0.66 ACHE (0.44) SIGMAR1KDM5BBCHEACHECHRM2
Trifluoroacetic Acid SCHEMBL589964 0.66 EPHX2 (0.40) CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318750-B2 Organic compounds NOVARTIS AG (NL) 2012-11-27 US disclosed
US-8258141-B2 Organic compounds NOVARTIS AG (CH) 2012-09-04 US disclosed
US-20100286126-A1 Organic Compounds NOVARTIS AG (CH) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286126-A1 Organic Compounds CYP3A43, SLCO1B3, CYP2C19 SIGMAR1 134/4885KDM5B 4457/4885BCHE 3026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.